Marken Launches Cord Blood Service In The US And Latin America
RESEARCH TRIANGLE PARK, N.C., June 6, 2012 /PRNewswire/ — Marken announced today that it has successfully rolled out a new comprehensive service to collect and deliver cord blood from US and Latin American hospitals to storage facilities in the United States. Cord blood is a sample of blood collected from a baby’s umbilical cord and placenta at the time of birth. This blood is a rich source of stem cells, which are increasingly used in the treatment of a wide range of diseases. The collection and long term storage of stem cells is a growing trend for young families and are the subject of increased regulation.
This new service offered by Marken covers the United States and a growing number of countries in Latin America. Cord blood distribution demands the kind of special attention that Marken is known for. Cord blood samples need to be delivered within 48 hours from time of birth to the final storage destination while maintaining a temperature of 4- 30C in special packaging. This service is made possible through Marken’s 24/7 customer call center in its New York and Miami branch offices and its supporting operations in Los Angeles and San Francisco.
“We are very proud to announce this new service,” said Wes Wheeler, CEO. “The collection and special handling of cord blood is very personal for new mothers and their families. The blood samples we collect contain very delicate, pure stem cells that are increasingly used in the treatment of brain injury and Type I Diabetes, with more uses under study. We view this as a perfect additional service to offer our increasing number of healthcare clients as we continue to grow into the Diagnostic sector.”
Marken is the leading global clinical supply chain solutions provider dedicated 100% to the pharmaceutical and life sciences industries, supporting over 49,000 investigator sites in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment naive geographies. Our team members and network of facilities bridge the distance between patients and the essential resources of life science companies.